Bioceres, which sells biologic agrochemicals and develops seed productivity traits in Argentina, has postponed its IPO, citing market conditions. The Rosario, Argentina-based company had planned to raise $130 million by offering 11.8 million shares at a price range of $10 to $12.
Bioceres was founded in 2001 and booked $128 million in sales for the 12 months ended September 30, 2017. It had planned to dual list on the NYSE and Bolsas y Mercados Argentinos (BYMA) under the symbol BIOX. Jefferies, Piper Jaffray, Santander and SunTrust Robinson Humphrey were set to be the joint bookrunners on the deal.
